| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.2M | -42.8% |
| Cost of Revenue | $24.7M | -41.2% |
| Gross Profit | $3.5M | -51.7% |
| R&D Expense | $600K | -66.7% |
| Operating Income | -$27.5M | -136.2% |
| Pre-tax Income | -$27.4M | -140.9% |
| Income Tax | -$406K | -331.9% |
| Net Income | -$27.0M | -139.3% |
| EPS (Basic) | -$1.61 | -109.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $969K | -78.8% |
| Accounts Receivable | $8.2M | +2.6% |
| Inventory | $9.8M | -20.5% |
| Current Assets | $21.0M | -22.4% |
| Total Assets | $42.7M | -30.5% |
| Current Liabilities | $12.1M | -9.1% |
| Total Liabilities | $17.9M | -11.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.5M | -378.0% |
| Capital Expenditures | $418K | -49.5% |
| Investing Cash Flow | -$482K | +88.1% |
| Financing Cash Flow | $7.5M | +520.7% |
| Free Cash Flow | -$10.9M | -260.8% |
| $24.8M |
| -39.8% |